Cofilin 1 promotes the aggregation and cell-to-cell transmission of α-synuclein in Parkinson's disease

Biochem Biophys Res Commun. 2020 Sep 3;529(4):1053-1060. doi: 10.1016/j.bbrc.2020.06.101. Epub 2020 Jul 30.

Abstract

The histopathological hallmark of Parkinson's disease (PD) is the presence of fibrillar aggregates referred to as Lewy bodies (LBs), in which α-synuclein is the major component. Converging evidence supports the prion-like transmission of α-synuclein aggregates in the onset and progression of PD. Intracellular α-synuclein aggregates into pathological fibrils, which can be transferred from aggregate-producing cells to aggregate-free cells, triggering neuronal injury and the progression of pathology. However, the specific mechanisms mediating the aggregation and transmission of pathological α-synuclein remain unknown. Here we show that cofilin 1 binds to α-synuclein and promotes its aggregation. The mixed fibrils consist of cofilin 1 and α-synuclein are more compact and more potent than pure α-synuclein fibrils in seeding α-synuclein aggregation. Cofilin 1 also facilitates the uptake of α-synuclein fibrils and finally induces neuronal dysfunction. Together, these observations indicate that cofilin 1 acts as a crucial mediator in the aggregation and propagation of pathological α-synuclein, contributing to the pathogenesis of PD.

Keywords: Aggregation; Cofilin 1; Seeds; Transmission; α-Synuclein.

MeSH terms

  • Animals
  • Brain / metabolism
  • Brain / pathology
  • Cofilin 1 / metabolism*
  • HEK293 Cells
  • Humans
  • Mice, Transgenic
  • Parkinson Disease / metabolism*
  • Protein Aggregates*
  • Protein Binding
  • alpha-Synuclein / metabolism*
  • alpha-Synuclein / toxicity

Substances

  • Cofilin 1
  • Protein Aggregates
  • alpha-Synuclein